Results 201 to 210 of about 168,560 (263)
Thromboelastographic description of intraoperative coagulopathy in patients undergoing liver transplant surgery: A single-center observational study. [PDF]
World J TransplantMaroun W +11 more
europepmc +1 more source
Association between fibrinogen-albumin ratio and outcomes in myocardial infarction: A systematic review and meta-analysis. [PDF]
Pak J Med SciXu P, Xu H, Shen S, Zhu J, Shen W.
europepmc +1 more source
Comment on: Fibrinogen Changes Before and After Intravenous Thrombolysis as Predictors of Cerebral Injury and Clinical Outcomes in Acute Ischemic Stroke-The 24-h Time-Point May be a Pro-Thrombotic Blind Spot: Check 6-h Fibrinogen Rebound to Catch Early Re-Occluders. [PDF]
Ann Clin Transl NeurolFang Q, Ying L, Gong Y.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The International Journal of Biochemistry & Cell Biology, 1999
Fibrinogen is a blood-borne glycoprotein comprised of three pairs of nonidentical polypeptide chains. Following vascular injury, fibrinogen is cleaved by thrombin to form fibrin which is the most abundant component of blood clots. As well as controlling blood loss at sites of tissue damage, other properties of fibrinogen have recently been discovered ...
Herrick, SE; id_orcid 0000-0002-9085-5664 +3 more
openaire +3 more sources
Fibrinogen is a blood-borne glycoprotein comprised of three pairs of nonidentical polypeptide chains. Following vascular injury, fibrinogen is cleaved by thrombin to form fibrin which is the most abundant component of blood clots. As well as controlling blood loss at sites of tissue damage, other properties of fibrinogen have recently been discovered ...
Herrick, SE; id_orcid 0000-0002-9085-5664 +3 more
openaire +3 more sources
Thrombosis Research, 1989
Effet d'un traitement a la pentoxifylline chez des patients atteints de maladie vasculaire peripherique au stade II, sur les taux plasmatiques de fibrinogene. Correlation entre la diminution des taux de fibrinogene et l'amelioration de l'etat de sante des patients, exprimee par le pourcentage d'augmentation de la distance parcourue a pied lors d'un ...
P, Bachet, S, Lancrenon, G, Chassoux
openaire +2 more sources
Effet d'un traitement a la pentoxifylline chez des patients atteints de maladie vasculaire peripherique au stade II, sur les taux plasmatiques de fibrinogene. Correlation entre la diminution des taux de fibrinogene et l'amelioration de l'etat de sante des patients, exprimee par le pourcentage d'augmentation de la distance parcourue a pied lors d'un ...
P, Bachet, S, Lancrenon, G, Chassoux
openaire +2 more sources
Fibrinogen Amsterdam, Another Hereditary Abnormality of Fibrinogen
British Journal of Haematology, 1971Summary. A coagulation defect, characterized by a prolonged thrombin and pro‐thrombin time, was discovered in a family without haemorrhagic diathesis. The disorder is caused by a delayed aggregation of fibrin monomers. Patient's and normal purified fibrin monomers showed the same aggregation properties, but the patient's fibrin monomers aggregated ...
C L, Janssen, J, Vreeken
openaire +3 more sources
Aging Clinical and Experimental Research, 1994
Plasma fibrinogen concentration is becoming widely accepted as a risk factor for cardio- and cerebrovascular disease. In order to evaluate its age-dependency, plasma fibrinogen and several other blood components were determined in 156 persons (23-96 years).
K, Hager +3 more
openaire +2 more sources
Plasma fibrinogen concentration is becoming widely accepted as a risk factor for cardio- and cerebrovascular disease. In order to evaluate its age-dependency, plasma fibrinogen and several other blood components were determined in 156 persons (23-96 years).
K, Hager +3 more
openaire +2 more sources
2013
Fibrinogen is the final essential building block of the clotting process. Thus, all of the preliminary "cause and effect" events in the clotting cascade rely on the work of this molecule to measure their success. The most commonly used laboratory method for measuring fibrinogen is the Clauss fibrinogen assay.
Linda J, Stang, Lesley G, Mitchell
openaire +2 more sources
Fibrinogen is the final essential building block of the clotting process. Thus, all of the preliminary "cause and effect" events in the clotting cascade rely on the work of this molecule to measure their success. The most commonly used laboratory method for measuring fibrinogen is the Clauss fibrinogen assay.
Linda J, Stang, Lesley G, Mitchell
openaire +2 more sources